US National OCS Liver Perfusion (OLP) Registry
This study is a registry collecting information on liver transplant patients. It is looking at how well patients do after receiving a liver that was preserved using the TransMedics® Organ Care System (OCS) Liver, which is an FDA-approved device. The study will compare these patients to those whose livers were preserved using other methods. The main goal is to see how long patients survive after transplant, specifically at 5 years. Anyone who has received a liver transplant can be included in this registry.
- Study design
- This is an observational study, meaning researchers will collect information without giving new treatments. It plans to include 100,000 liver transplant recipients.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 5 years after their liver transplant to measure survival.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
US National OCS Liver Perfusion (OLP) Registry
At a glance
Conditions
Where it's being run
22 sites across 16 statesStudy leadership
- Ahmed Elbetanony, MD · STUDY_DIRECTOR · TransMedics
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Survival5 years post-transplant
Recipients' patient and graft survival rates will be the primary clinical outcomes measures for all OCS Liver transplanted recipients compared to recipients receiving liver transplants using non-OCS preservation methods (cold static storage or other perfusion devices or a combination of both). This data will be obtained directly from UNOS/OPTN database.